Evidence map›Paper›PMID 42227022›Full record

ArticleDevelopment (Cambridge, England)2026

The roles of the acetyltransferase domains of the chromatin regulators KAT6A and KAT6B in vivo.

Tim Thomas, Shezlie Malelang, Yuqing Yang, Maria I Bergamasco, Andrew J Kueh, Alexandra L Garnham, Nishika Ranathunga, Gordon K Smyth, Anne K Voss

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tim ThomasThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.ORCID 0000-0002-7623-8344
Shezlie MalelangThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.
Yuqing YangThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.
Maria I BergamascoThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.
Andrew J KuehThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.
Alexandra L GarnhamThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.
Nishika RanathungaThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.
Gordon K SmythThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.
Anne K VossThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.

Funding

Australian GovernmentLorenzo and Pamela Galli Charitable TrustNational Collaborative Research Infrastructure StrategyNational Health and Medical Research Council 1081421National Health and Medical Research Council 1154970National Health and Medical Research Council 1160517National Health and Medical Research Council 1176789National Health and Medical Research Council 1194345National Health and Medical Research Council 2010711National Health and Medical Research Council 2025645Phenomics AustraliaState Government of VictoriaThe University of MelbourneVictorian Government Operational Infrastructure Support Grant
6 · The paper itself

Abstract

KAT6A (MOZ) and KAT6B (QKF/MORF) are related histone lysine acetyltransferases (KATs) that have a high degree of functional redundancy during development. In the absence of KAT6A, embryos undergo an anterior homeotic transformation of the axial skeleton, develop an interrupted aortic arch, have ventricular septal defects and fail to form definitive hematopoietic stem cells. KAT6B has roles in brain, skeletal and hematopoietic system development. Because loss of KAT6A leads to highly penetrant phenotypes, this allows us to determine whether the acetylation function is essential for all activities. We show that loss of acetyltransferase activity did not phenocopy the loss of the KAT6A protein in mice. Although mutation of the KAT domains of both KAT6A and KAT6B together increased the severity of phenotypes observed, these were milder than complete KAT6A loss of function. KAT domain mutants displayed ventricular septal defects and reduced (but not eliminated) hematopoietic stem cell activity. However, they did not display homeotic transformations or aortic arch defects, suggesting that, while acetylation is important for some functions, others can proceed without this activity. Accordingly, KAT6 proteins appear to have functions beyond acetylation.

Indexed as

ChromatinHistone AcetyltransferasesAcetylationAnimalsHeart Septal Defects, VentricularHematopoietic Stem CellsMiceMutationPhenotypeProtein DomainsChromatinHistone AcetyltransferasesKat6b protein, mouseMOZ protein, mouseHeart developmentHematopoietic stem cellsHistone acetyltransferaseKAT6AKAT6BMORFMouseMOZQKFSkeleton

Identifiers

PMID42227022
PMCPMC13327545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.